Eva Pérez Pampín-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis

    Rheumatology International, Vol. 38, Núm. 4, pp. 589-598

2017

  1. Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

    Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942

  2. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis

    Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155

2016

  1. Centre-related variability in hospital admissions of patients with spondyloarthritis

    Rheumatology International, Vol. 36, Núm. 9, pp. 1301-1308

  2. Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580

2015

  1. Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640

2013

  1. Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy

    Journal of Rheumatology, Vol. 40, Núm. 11, pp. 1850-1855